Prolactin receptors in the male Rana esculenta

Distribution of prolactin receptor in frog (Rana ridibunda) dorsal skin during hibernation

The role of prolactin in the regulation of frog skin functions is still unclear particularly during environmental changes. In this study, prolactin receptor (PRLR) was detected in active and hibernating frog dorsal skin using immunohistochemical method. PRLR immunoreactivity in active frogs was observed in the epidermis, in the secretory epithelium of granular glands and the secretory channel cells of the glands. Myoepithelial cells of granular glands that started accumulating secretory material or those with a full lumen were PRLR immunoreactive, while some myoepithelial cells of empty granular glands were negative for PRLR. In hibernating frogs, this immunoreactivity was observed in the same regions; however, immunoreactivity was more intense than that in active frogs. PCNA was employed for detection of proliferative activity of PRL in the dorsal skin, and immunoreactivity was detected in the nuclei of a few epidermis cells and in the duct of glands of active frogs. The number of immunoreactive nuclei in these regions increased in hibernating and in prolactin injected groups. We conclude that prolactin provides morphological and functional integrity of skin stimulating the proliferation and regulating the function of granular glands and plays an important role in the adaptation of amphibians to the long winter period.

Effects of prolactin, growth hormone, and triiodothyronine on prolactin receptors in larval and adult tiger salamanders (Ambystoma tigrinum)

The effects of porcine growth hormone (pGH) or ovine prolactin (oPRL) alone and in combination with triiodothyronine (T3) on renal PRL receptors were determined in both pre- and post-metamorphic tiger salamanders (Ambystoma tigrinum). The protein hormones were given at a dose of 1.0 micrograms/gm body weight/day and the T3 was given at 10.0 ng/gm body weight/day. The duration of treatment was 7 days. Effects on growth, and plasma thyroid hormone levels were also determined. Ovine PRL increased growth in both larvae and adults and reversed metamorphic changes. Administration of T3 increased the plasma T3 concentration, as measured by radioimmunoassay, and when given alone caused weight loss at both stages. The GH decreased plasma T4 and increased plasma T3 concentrations, indicating that it caused an increase in T4 deiodination. In adults the renal PRL receptor affinity of 2.9 +/- 0.7 x 10(10) L/mol and capacity of 160 +/- 22 fmol/mg protein were higher than the corresponding values of 1.8 +/- 0.3 x 10(10) L/mol and 29.2 +/- 3.8 fmol/mg in larvae. In adults only, there is an additional low-affinity, high capacity PRL binding site. The oPRL treatment decreased the binding capacity of 33.2 +/- 1.2 and 5.9 +/- 4.9 fmol/mg in adults and larvae, respectively. By contrast, pGH increased the capacities to 249 +/- 18 and 62.1 +/- 6.8 fmol/mg in adults and larvae, respectively. Treatment with T3 alone doubled the oPRL binding capacity to 58.3 +/- 4.7 fmol/mg in larvae, but there was no effect in adults. In both developmental stages the effects of oPRL and pGH on the receptors were not changed by the simultaneous T3 treatment.(ABSTRACT TRUNCATED AT 250 WORDS)

Does prolactin play a role in skin biology and pathology?

Despite its extensive repertoire of biological activities, which include the growth- and osmoregulation of epithelial tissues as well as immunoregulatory properties, the potential significance of the pituitary hormone prolactin (PRL) for human skin biology and pathology has yet to be fully appreciated. In this essay, the hypothesis is presented that PRL acts as a neuroendocrine modulator of skin epithelial cell proliferation and of the skin immune system by forming a 'prolactin-circuit' between the central nervous system and the skin. Binding to specific skin receptors, modulation of cytokine release in the skin, and stimulation of somatomedin release by mesenchymal cells are among the suggested pathways by which PRL could affect epithelial cell growth in the skin. Potential feedback signals, arising from the skin and modifying pituitary PRL release, are briefly outlined. Centering on the role of PRL in both psoriasis and hair growth as models for studying the proposed PRL-skin connection, clinical and experimental evidence in support of this theory is discussed in the context of a 'neuroimmune-dermatological' perspective.

Presence of prolactin receptors in kidney and large intestine of the snake Ptyas mucosa

125I-labeled ovine prolactin was used to test for the presence of prolactin receptors in membranes prepared from tissues of the common rat snake Ptyas mucosa. High levels of specific binding were found in kidney and large intestine membranes prepared from snakes of both sexes. The binding was time, temperature, and protein dependent. The presence of Ca2+ in the incubation medium enhanced the binding, with optimal concentrations at 10-20 mM. Specificity of binding was established by employing different hormones as the displacing species in the radioreceptor assay. The results suggested the presence of lactogenic receptors in snake kidney and large intestine membranes. Scatchard analysis of the binding data indicated the presence of a single class of binding sites in snake kidney membranes with a dissociation constant of 0.83 nM. The present study is the first report of the presence of prolactin receptors in snake kidney and large intestine membranes.

Effect of hypophysectomy, replacement therapy with ovine prolactin, and cortisol and triiodothyronine treatment on prolactin receptors of the tilapia (Oreochromis mossambicus)

The effects of hypophysectomy and subsequent replacement therapy with ovine prolactin (oPRL) on specific binding of 125I-oPRL to gill, kidney, and liver membranes of male tilapia were examined. The possible control of prolactin receptors by cortisol (F) and triiodothyronine (T3) was also studied using intact animals. In gill and kidney, hypophysectomy resulted in a significant decrease in specific binding that was partially restored (threefold increase) by three injections of oPRL, suggesting a role of the pituitary in the control of prolactin receptors. However, removal of the pituitary and replacement therapy with oPRL had no effect on binding by liver membranes. Cortisol and T3 treatment, alone or in combination, did not significantly affect prolactin binding by any of the tissues tested.

Prolactin receptors in liver, kidney, and gill of the tilapia (Oreochromis mossambicus): characterization and effect of salinity on specific binding of iodinated ovine prolactin

Specific binding of 125I-ovine prolactin (oPRL) to microsomal fractions from gill, kidney, and liver of adult tilapia was determined. Specific binding varied among tissues, the highest values being displayed by kidney membranes. In the liver, the binding of oPRL was not strongly displaced by tilapia prolactins (tPRL177 and tPRL188), although tPRL177 was six times more potent than tPRL188. On the other hand, in kidney and gill membranes, the two tPRLs were equipotent. Tilapia PRLs showed low potency in competing for oPRL-binding sites when pregnant rat liver membranes were utilized. Tilapia growth hormone (tGH) and human growth hormone (hGH) displaced 125I-oPRL from liver as well as did tPRL177 but were not recognized well by renal or branchial receptors. Two 125I-oPRL-binding sites were detected in every tissue tested. These binding sites are subject to physiological regulation since adaptation to seawater resulted in a significant decrease in specific binding.